Abstract | AIMS: To assess sleep quality in patients with primary headaches before and after prophylactic treatment using a validated sleep-screening instrument. MATERIALS AND METHODS: RESULTS: Baseline Visual Analogue Score (VAS) in migraine patients was 7.99 ± 1.39 compared with 6.86 ± 1.50 in TTH group (P < 0.001). VAS score after the first month of treatment was 6.08 ± 1.88 in migraine patients and 5.40 ± 1.61 in TTH (P = 0.023). VAS scores decreased after the third month of treatment to 4.32 ± 2.29 in migraine patients and 4.11 ± 1.66 in TTH patients (P = 0.344). The decrease was significant for patients treated with amitriptyline but not for those with propranolol. Baseline Pittsburgh Sleep Quality (PSQI) scores were 5.93 ± 2.43 in migraine patients and 6.71 ± 2.39 in TTH patients. Poor quality of sleep (PSQI ≥ 6) prior to prophylactic treatment was observed in 61.4% of migraine patients and in 77.7% of TTH patients. Comparison of PSQI scores before and 3 months following treatment showed significantly improved quality of sleep in all treatment groups; the greatest significance was detected in migraine patients with initial PSQI scores of ≥6 and treated with amitriptyline (P < 0.001). CONCLUSIONS: Increased understanding of routine objective sleep measures in migraine patients is needed to clarify the nature of sleep disturbances associated with primary headaches. This may in turn lead to improvements in headache treatments.
|
Authors | Taşkın Duman, Özlem H Dede, Derya Uluduz, Gülşah Seydaoğlu, Esra Okuyucu, İsmet Melek |
Journal | Annals of Indian Academy of Neurology
(Ann Indian Acad Neurol)
2015 Jul-Sep
Vol. 18
Issue 3
Pg. 298-302
ISSN: 0972-2327 [Print] India |
PMID | 26425007
(Publication Type: Journal Article)
|